Randomized controlled trial of rituximab and cost-effectiveness analysis in treating fatigue and oral dryness in primary Sjögren's Syndrome
- Submitting institution
-
University of Sussex
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 146105_67451
- Type
- D - Journal article
- DOI
-
10.1002/art.40093
- Title of journal
- Arthritis and Rheumatology
- Article number
- -
- First page
- 1440
- Volume
- 69
- Issue
- 7
- ISSN
- 2326-5191
- Open access status
- Other exception
- Month of publication
- March
- Year of publication
- 2017
- URL
-
https://doi.org/10.1002/art.40093
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
22
- Research group(s)
-
-
- Citation count
- 82
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- The author made a substantial contribution to the conception and design of the study and critiqued the output for important intellectual content.
- Non-English
- No
- English abstract
- -
